Legal Representation
Attorney
Michael T. Smith
USPTO Deadlines
Next Deadline
1829 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-06)
Due Date
August 06, 2030
Grace Period Ends
February 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 6, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 6, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 2, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 2, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 6, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 6, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 14, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 14, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 7, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 5, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 5, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 1, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 31, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 31, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 26, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 2, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 31, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Incubation services, namely, providing work space and access to work space containing business equipment and lab equipment to emerging and start-up companies; business incubator services, namely, facilitating innovation and collaborative interactions between universities, research institutions, technology start-ups, and the business community; business advisory and business strategic planning services, namely, providing consulting and business information; business development services, namely, providing start-up support for businesses of others
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Class 040
Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Custom manufacture of nutraceuticals; Custom manufacture of vitamins for humans
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Class 042
Developing products for others; developing medicine services; scientific research and development; medicine research; research and development of new products; technical consulting services in the field of technology development of biologics; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies; Scientific laboratory services, namely, providing shared wet laboratory facilities and shared laboratory apparatus and instruments for others
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Classification
International Classes
035
040
042